High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts

por Wähämaa, Heidi, Schierbeck, Hanna, Hreggvidsdottir, Hulda S, Palmblad, Karin, Aveberger, Anne-Charlotte, Andersson, Ulf, Harris, Helena Erlandsson
Publicado 2011

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus

por Wirestam, Lina, Schierbeck, Hanna, Skogh, Thomas, Gunnarsson, Iva, Ottosson, Lars, Erlandsson-Harris, Helena, Wetterö, Jonas, Sjöwall, Christopher
Publicado 2015

Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

por Palmblad, Karin, Schierbeck, Hanna, Sundberg, Erik, Horne, Anna-Carin, Erlandsson Harris, Helena, Henter, Jan-Inge, Andersson, Ulf
Publicado 2021

Cytokine active disulfide-HMGB1 increased during severe macrophage activation syndrome

por Schierbeck, Hanna, Sundberg, Erik, Palmblad, Karin, Horne, AnnaCarin, Harris, Helena Erlandsson, Henter, Jan-Inge, Antoine, Dan, Andersson, Ulf
Publicado 2014

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

por Palmblad, Karin, Schierbeck, Hanna, Sundberg, Erik, Horne, Anna-Carin, Harris, Helena Erlandsson, Henter, Jan-Inge, Antoine, Daniel J., Andersson, Ulf
Publicado 2020

Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

por Palmblad, Karin, Schierbeck, Hanna, Sundberg, Erik, Horne, Anna-Carin, Harris, Helena Erlandsson, Henter, Jan-Inge, Antoine, Daniel J., Andersson, Ulf
Publicado 2020